Organ Preservation Solutions

Organ Preservation Solutions Market (By Solutions - Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and Others, and By Preservation Techniques- Hypothermic Perfusion Preservation, Static Cold Storage and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • Rep Id : TMRGL1786
  • Published On : Feb 2014
  • No. of Pages : 78
  • Category : Pharmaceutical

 

Chapter 1 Introduction

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

 

Chapter 2 Executive Summary

 

Chapter 3 Market Overview

3.1 Introduction

3.2 Market Drivers

      3.2.1 Aging global population

              3.2.1.1 Global rate of aging population

      3.2.2 Technological advancements

      3.2.3 Increasing reimbursement scenario

      3.2.4 Increase in per capita healthcare expenditure

3.3 Market Restraints

      3.3.1 Lack of organ donors

              3.3.1.1 Widening Gap Between Patients Receiving Organ Transplants and Number of Donors in the U.S. (1998 - 2010)

      3.3.2 High cost of procedure

3.4 Market Opportunities

      3.4.1 Collaboration with research-oriented organizations and medical institutes to ensure retention of customer base

3.5 Porter’s Five Force Analysis for the Global Organ Preservation Solutions Market

      3.5.1 Bargaining power of suppliers

      3.5.2 Bargaining power of buyers

      3.5.3 Threat of substitutes

      3.5.4 Threat of new entrants

      3.5.5 Competitive rivalry

3.6 Market Attractiveness Analysis: Global Organ Preservation Solutions Market, by Geography

 

Chapter 4 Global Organ Preservation Solutions Market, By Solution, 2011 – 2019 (USD Million)

4.1 Overview

      4.1.1 Global Organ Preservation Solutions Market Revenue, by Solution Type, 2011 - 2019 (USD Million)

      4.1.2 Comparative Analysis: Global Organ Preservation Solutions Market, by Solution Type, 2012 & 2019 (Value %)

4.2 Viaspan

      4.2.1 Global Viaspan Market Revenue, 2011 - 2019 (USD Million)

4.3 Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution

      4.3.1 Global Custodiol Market Revenue, 2011 - 2019 (USD Million)

4.4 Renograf

      4.4.1 Global Renograf Market Revenue, 2011 - 2019 (USD Million)

4.5 Hypothermosol

      4.5.1 Global Hypothermosol Market Revenue, 2011 - 2019 (USD Million)

4.6 Perfadex

      4.6.1 Global Perfadex Market Revenue, 2011 - 2019 (USD Million)

4.7 Lifor

      4.7.1 Global Lifor Market Revenue, 2011 - 2019 (USD Million)

4.8 Human bioSystem (HBS) Solution

      4.8.1 Global HBS Solution Market Revenue, 2011 - 2019 (USD Million)

4.9 siRNA Transplant Solution

      4.9.1 Global siRNA Transplant Solution Market Revenue, 2011 - 2019 (USD Million)

4.10 Others

      4.10.1 Global Other Solutions Market Revenue, 2011 - 2019 (USD Million)

 

Chapter 5 Global Organ Preservation Solutions Market, By Preservation Technique, 2011 – 2019 (USD Million)

5.1 Overview

      5.1.1 Global Organ Preservation Solutions Market Revenue, by Preservation Technique, 2011 - 2019 (USD Million)

      5.1.2 Comparative Analysis: Global Organ Preservation Solutions Market, by Preservation Technique, 2012 & 2019 (Value %)

5.2 Hypothermic Perfusion Preservation (HPP)

      5.2.1 Global Hypothermic Perfusion Preservation Market Revenue, 2011 - 2019 (USD Million)

5.3 Static Cold Storage (SCS)

      5.3.1 Global Static Cold Storage Market Revenue, 2011 - 2019 (USD Million)

5.4 Others

      5.4.1 Global Other Preservation Techniques Market Revenue, 2011 - 2019 (USD Million)

 

Chapter 6 Global Organ Preservation Solutions Market, By Geography, 2011 – 2019 (USD Million)

6.1 Overview

      6.1.1 Global Organ Preservation Solutions Market Revenue, by Geography, 2011 - 2019 (USD Million)

      6.1.2 Comparative Analysis: Global Organ Preservation Solutions Market, by Geography, 2012 & 2019 (Value %)

6.2 North America

      6.2.1 North America Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)

6.3 Europe

      6.3.1 Europe Deceased Donation Rate (Per Million of Population), by Country, 2011

      6.3.2 Europe Organ Donation and Transplantation Data, 2011

      6.3.3 Donation and Transplantation Number Per European Country, 2011

      6.3.4 Europe Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)

6.4 Asia Pacific

      6.4.1 Organ Donation and Transplantation Data for Japan (2009 - 2013)

      6.4.2 Asia Pacific Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)

6.5 Rest of the World (RoW)

      6.5.1 RoW Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)

 

Chapter 7 Competitive Landscape

7.1 Market Share by Key Players, 2012 (%)

 

Chapter 8 Recommendations

8.1 Long term contracts with healthcare service providers

8.2 Broadening of distribution network

8.3 Product innovation

 

Chapter 9 Company Profiles

9.1 21st Century Medicine

      9.1.1 Company Overview

      9.1.2 Product Portfolio

9.2 BioLife Solutions, Inc.

      9.2.1 Company Overview

      9.2.2 Financial Overview

      9.2.3 Product Portfolio

      9.2.4 Business Strategies

      9.2.5 Recent Developments

9.3 BioTime, Inc.

      9.3.1 Company Overview

      9.3.2 Financial Overview

      9.3.3 Product Portfolio

      9.3.4 Business Strategies

      9.3.5 Recent Developments

9.4 Bristol-Myers Squibb

      9.4.1 Company Overview

      9.4.2 Financial Overview

      9.4.3 Product Portfolio

      9.4.4 Business Strategies

      9.4.5 Recent Developments

9.5 Claris Lifesciences Limited

      9.5.1 Company Overview

      9.5.2 Financial Overview

      9.5.3 Product Portfolio

      9.5.4 Business Strategies

      9.5.5 Recent Developments

9.6 CryoLife, Inc.

      9.6.1 Company Overview

      9.6.2 Financial Overview

      9.6.3 Product Portfolio

      9.6.4 Business Strategies

      9.6.5 Recent Developments

9.7 Dr. Franz Köhler Chemie GmbH

      9.7.1 Company Overview

      9.7.2 Product Portfolio

      9.7.3 Business Strategies

9.8 Lifeline Scientific

      9.8.1 Company Profile

      9.8.2 Financial Overview

      9.8.3 Product Portfolio

      9.8.4 Business Strategies

      9.8.5 Recent Developments

9.9 Teva Pharmaceutical Industries Ltd.

      9.9.1 Company Profile

      9.9.2 Financial Overview

      9.9.3 Product Portfolio

      9.9.4 Business Strategies

      9.9.5 Recent Developments

9.10 ToleroTech, Inc.

      9.10.1 Company Profile

      9.10.2 Product Portfolio

      9.10.3 Business Strategies

9.11 XVIVO Perfusion AB

      9.11.1 Company Overview

      9.11.2 Financial Overview

      9.11.3 Product Portfolio

      9.11.4 Business Strategies

List of Tables

 

TABLE 1 Market Snapshot: Global Organ Preservation Solutions Market

TABLE 2 Global Organ Preservation Solutions Market Revenue, by Solution, 2011 – 2019 (USD Million)

TABLE 3 Global Organ Preservation Solutions Market Revenue, by Preservation Technique, 2011 – 2019 (USD Million)

TABLE 4 Global Organ Preservation Solutions Market Revenue, by Geography, 2011 – 2019 (USD Million)

TABLE 5 Organ Donation and Transplantation Data for Japan (2009 - 2013)

List of Figures

 

FIG. 1 Organ Preservation Solutions Market Segmentation

FIG. 2 Global Organ Preservation Solutions Market, by Solution, 2012 (USD Million)

FIG. 3 Global Organ Preservation Solutions Market, by Preservation Technique, 2012 (USD Million)

FIG. 4 Global Rate of Aging Population

FIG. 5 Gap Between Organ Transplant and Donors in the U.S. (1998 - 2010)

FIG. 6 Porter’s Five Force Analysis: Global Organ Preservation Solutions Market

FIG. 7 Market Attractiveness Analysis: Global Organ Preservation Solutions Market, by Geography

FIG. 8 Comparative Analysis: Global Organ Preservation Solutions Market, by Solution Type, 2012 & 2019 (Value %)

FIG. 9 Global Viaspan Market Revenue, 2011 – 2019 (USD Million)

FIG. 10 Global Custodiol Market Revenue, 2011 – 2019 (USD Million)

FIG. 11 Global Renograf Market Revenue, 2011 – 2019 (USD Million)

FIG. 12 Global Hypothermosol Market Revenue, 2011 – 2019 (USD Million)

FIG. 13 Global Perfadex Market Revenue, 2011 – 2019 (USD Million)

FIG. 14 Global Lifor Market Revenue, 2011 – 2019 (USD Million)

FIG. 15 Global HBS Solution Market Revenue, 2011 – 2019 (USD Million)

FIG. 16 Global siRNA Transplant Solution Market Revenue, 2011 – 2019 (USD Million)

FIG. 17 Global Other Solutions Market Revenue, 2011 – 2019 (USD Million)

FIG. 18 Comparative Analysis: Global Organ Preservation Solution Market, by Preservation Technique, 2012 & 2019 (Value %)

FIG. 19 Global Hypothermic Perfusion Preservation Market Revenue, 2011 – 2019 (USD Million)

FIG. 20 Global Static Cold Storage Market Revenue, 2011 – 2019 (USD Million)

FIG. 21 Global Other Preservation Techniques Market Revenue, 2011 – 2019 (USD Million)

FIG. 22 Comparative Analysis: Global Organ Preservation Solution Market, by Geography, 2012 & 2019 (Value %)

FIG. 23 North America Organ Preservation Solutions Market Revenue, 2011 – 2019 (USD Million)

FIG. 24 Europe Organ Preservation Solutions Market Revenue, 2011 – 2019 (USD Million)

FIG. 25 Asia Pacific Organ Preservation Solutions Market Revenue, 2011 – 2019 (USD Million)

FIG. 26 RoW Organ Preservation Solutions Market Revenue, 2011 – 2019 (USD Million)

FIG. 27 Market Share by Key Players, 2012 (%)

FIG. 28 Annual Revenue: BioLife Solutions, Inc., 2010 – 2012 (USD Million)

FIG. 29 Annual Revenue: BioTime Inc., 2010 – 2012 (USD Million)

FIG. 30 Annual Revenue: Bristol-Myers Squibb, 2010 – 2012 (USD Million)

FIG. 31 Annual Sales: Claris Lifesciences Ltd., 2010 – 2012 (USD Million)

FIG. 32 Annual Revenue: CryoLife, Inc., 2010 – 2012 (USD Million)

FIG. 33 Annual Revenue: Lifeline Scientific, 2010 – 2012 (USD Million)

FIG. 34 Annual Revenue: Teva Pharmaceutical Industries Ltd., 2010 – 2012 (USD Million)

FIG. 35 Annual Sales: XVIVO Perfusion AB, 2010 – 2012 (USD Million)

.